SCHEMBL821606

SCHEMBL821606

ONS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroxyl Radical SCHEMBL1847655 0.93
SCHEMBL929348 0.61
SCHEMBL4685684 0.61
Ammonia Solution, Strong SCHEMBL5697195 0.55
SCHEMBL1846678 0.55
Iodide SCHEMBL9818601 0.55
SCHEMBL15797702 0.55 CA2 (0.36)
SCHEMBL5869492 0.50
SCHEMBL10819265 0.50
SCHEMBL911109 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114058421-A Ashless dispersant for lubricating oil and preparation method thereof 中国石油天然气股份有限公司 2022-02-18 CN claimed
EP-1882729-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2012-05-02 EP claimed
EP-1916292-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2011-11-16 EP claimed
US-20110262653-A1 Method of Producing Color Change in a Web Substrate THE PROCTER & GAMBLE COMPANY 2011-10-27 US claimed
EP-1760138-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2011-09-14 EP claimed
EP-1916290-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2011-08-03 EP claimed
EP-2107914-A2 MEDICAL DEVICE CAPABLE OF RELEASING NO Arsenal Medical, Inc. (US) 2009-10-14 EP claimed
EP-2094326-A2 MEDICAL DEVICE CAPABLE OF RELEASING NO Arsenal Medical, Inc. (US) 2009-09-02 EP claimed
WO-2008055719-A2 MEDICAL DEVICE CAPABLE OF RELEASING NO ARSENAL MEDICAL, INC. (US) 2008-05-15 WO claimed
WO-2008055718-A2 MEDICAL DEVICE CAPABLE OF RELEASING NO ARSENAL MEDICAL INC. (US) 2008-05-15 WO claimed
US-20260083941-A1 URINARY CATHETER TREATMENT UNIV MICHIGAN REGENTS (US) 2026-03-26 US disclosed
US-12478767-B2 Urinary catheter treatment THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2025-11-25 US disclosed
EP-3600375-B1 BACTERIOCINS FOR CONTROL OF SALMONELLA ENTERICA NOMAD BIOSCIENCE GMBH (DE) 2025-11-05 EP disclosed
EP-4126079-B1 URINARY CATHETER TREATMENT UNIV MICHIGAN REGENTS (US) 2025-11-05 EP disclosed
US-12409254-B2 Catheter insert devices THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2025-09-09 US disclosed
US-5683615-A Magnetorheological fluid LORD CORPORATION (US) 1997-11-04 US disclosed
EP-0692931-A4 SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF GLYCOMED INC (US) 1996-03-20 EP disclosed
EP-0692931-A1 SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF GLYCOMED INCORPORATED (US) 1996-01-24 EP disclosed
WO-1994022309-A1 SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF GLYCOMED INCORPORATED (US) 1994-10-13 WO disclosed
EP-0108294-A2 Preparation from hydroxylammonium sulfate of alcoholic hydroxylamine solutions and of oximes, hydroxamic acids and other hydroxylammonium salts via alcoholic hydroxylamine solutions AlliedSignal Inc. (US) 1984-05-16 EP disclosed